Acrolein, Crotonaldehyde, and Arecoline. IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Vol. 128

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22310%2F21%3A43922776" target="_blank" >RIV/60461373:22310/21:43922776 - isvavai.cz</a>
Result on the web
<a href="https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Acrolein-Crotonaldehyde-And-Arecoline-2021" target="_blank" >https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Acrolein-Crotonaldehyde-And-Arecoline-2021</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Acrolein, Crotonaldehyde, and Arecoline. IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Vol. 128
Original language description
Published data on carcinogenicity of three chemical agents were reviewed and evaluated by a working group of independent experts. Acrolein was classified as “probably carcinogenic to humans” (Group 2A) on the basis of “sufficient” evidence of carcinogenicity in experimental animals and “strong” mechanistic evidence. Crotonaldehyde and arecoline were classified as “possibly carcinogenic to humans” (Group 2B) on the basis of “strong” mechanistic evidence. For all three agents, the evidence regarding cancer in humans was “inadequate”; no data were available for arecoline, and the few available studies of cancer in humans for acrolein and crotonaldehyde were generally small or uninformative.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)